Opioids: molecular basis of action
- 1 June 2001
- journal article
- Published by Wolters Kluwer Health in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 8 (3) , 166-171
- https://doi.org/10.1097/00060793-200106000-00010
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- A Single Nucleotide Polymorphic Mutation in the Human μ-Opioid Receptor Severely Impairs Receptor SignalingPublished by Elsevier ,2001
- Sequence variability and candidate gene analysis in complex disease: association of micro opioid receptor gene variation with substance dependenceHuman Molecular Genetics, 2000
- Allelic Variation S268P of the Human μ-Opioid Receptor Affects Both Desensitization and G Protein CouplingMolecular Pharmacology, 2000
- Role of nitric oxide in diabetes-induced attenuation of antinociceptive effect of morphine in miceEuropean Journal of Pharmacology, 2000
- Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responsesNature Genetics, 2000
- Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization studyJournal of Chemical Neuroanatomy, 2000
- Molecular Mechanisms and Regulation of Opioid Receptor SignalingAnnual Review of Pharmacology and Toxicology, 2000
- The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic miceEuropean Journal of Pharmacology, 2000
- The μ opiate receptor as a candidate gene for pain: Polymorphisms, variations in expression, nociception, and opiate responsesProceedings of the National Academy of Sciences, 1999
- Endogenous opioids: overview and current issuesDrug and Alcohol Dependence, 1998